Metlife Inc Stock Research

Market Summary

USD55.85+1.50

Delayed

2.76%

MET Alerts

1 major insider sales recently.
Big fall in Revenue (Y/Y)

MET Stock Price

MET RSI Chart

MET Valuation

Market Cap

43.5B

Price/Earnings (Trailing)

17.14

Price/Sales (Trailing)

0.62

EV/EBITDA

6.19

Price/Free Cashflow

3.3

MET Price/Sales (Trailing)

MET Profitability

EBT Margin

4.09%

Return on Equity

9.39%

Return on Assets

0.38%

Free Cashflow Yield

30.35%

MET Fundamentals

MET Revenue

Revenue (TTM)

69.9B

Revenue Y/Y

-18.78%

Revenue Q/Q

-26.74%

MET Earnings

Earnings (TTM)

2.5B

Earnings Y/Y

11.45%

Earnings Q/Q

240%

Price Action

52 Week Range

54.5277.36

(Low)(High)

Last 7 days

-2.0%

Last 30 days

-22.3%

Last 90 days

-22.8%

Trailing 12 Months

-19.9%

MET Financial Health

MET Investor Care

Dividend Yield

3.55%

Dividend/Share (TTM)

1.98

Buy Backs (1Y)

5.63%

Diluted EPS (TTM)

2.91

Peers (Alternatives to Metlife)

View All Peers In Detail

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
MET	43.5B	69.9B	-22.26%	-19.90%	17.14	0.62	-1.66%	-61.26%
PRU	38.7B	60.0B	-19.83%	-31.95%	125.56	0.61	-15.34%	-118.62%
TRV	38.6B	36.9B	-9.77%	-9.50%	13.59	1.05	5.94%	-22.39%
RE	24.4B	12.1B	-9.44%	18.99%	40.95	2.03	1.63%	-56.71%
ATH	17.0B	7.6B	-	-	-9.57	0.74	-71.04%	-207.85%
GL	11.4B	5.2B	-11.08%	6.55%	15.43	2.19	2.00%	-0.71%
MID-CAP
PRI	6.0B	2.7B	-9.25%	22.62%	15.97	2.19	0.38%	-0.09%
LNC	3.6B	18.8B	-34.02%	-68.17%	-1.6	0.19	-2.32%	-258.51%
AEL	3.0B	1.4B	-11.34%	-8.75%	2.46	2.12	-61.63%	157.59%
BHF	2.9B	8.5B	-25.52%	-20.81%	574.08	0.34	18.64%	104.63%
GNW	2.4B	7.5B	-20.61%	30.10%	4.02	0.33	-4.15%	-32.63%
SMALL-CAP
VERY	119.9M	101.8M	15.75%	57.38%	-7.08	1.18	-19.68%	11.97%
AAME	49.1M	192.4M	3.33%	-12.98%	15.61	0.26	-8.30%	-76.65%
NSEC	41.4M	-	0.80%	56.55%	-121.51	0.63	-	-

Financials for Metlife

* denotes actual numbers (not divided by Millions)
Income Statement (Last 12 Months)					(In Millions)
Description	(%) Q/Q	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4
Revenue	-5.1%	69,898	73,671	68,306	71,274	71,080
Operating Expenses	-0.5%	12,034	12,097	12,658	12,456	12,586
S&GA Expenses	0.1%	5,270	5,264	5,463	-	-
EBITDA	12.8%	3,764	3,337	4,970	9,461	-
EBITDA Margin	18.9%	0.05*	0.05*	0.07*	0.13*	-
Earnings Before Taxes	17.3%	2,859	2,438	4,061	8,550	8,126
EBT Margin	23.6%	0.04*	0.03*	0.06*	0.12*	-
Interest Expenses	0.7%	905	899	909	911	914
Net Income	5.5%	2,539	2,406	3,595	6,870	6,554
Net Income Margin	11.2%	0.04*	0.03*	0.05*	0.10*	-
Free Cahsflow	-17.5%	13,204	16,010	15,238	13,054	-

Balance Sheet					(In Millions)
Description	(%) Q/Q	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4
Assets	2.5%	666,611	650,104	662,893	724,284	759,708
Cash Equivalents	-9.0%	20,195	22,200	20,548	23,488	20,047
Goodwill	3.2%	9,297	9,005	9,151	9,510	9,535
Liabilities	2.3%	639,324	624,774	625,526	670,047	691,959
. Short Term Borrowings	-4.4%	175	183	196	323	341
Shareholder's Equity	7.8%	27,040	25,076	37,367	54,237	67,482
Retained Earnings	2.2%	41,953	41,032	41,101	41,406	41,197
Additional Paid-In Capital	0.1%	33,616	33,589	33,548	33,531	33,511
Shares Outstanding	-1.0%	779	787	798	815	826
Minority Interest	-2.8%	247	254	266	272	267

Cashflow (Last 12 Months)					(In Millions)
Description	(%) Q/Q	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4
Cashflow From Operations	-17.5%	13,204	16,010	15,238	13,054	12,596
Cashflow From Investing	50.4%	-2,620	-5,285	-9,453	-10,559	-11,187
Cashflow From Financing	-49.9%	-10,108	-6,742	-9,625	1,140	-1,375
Dividend Payments	-0.7%	1,598	1,610	1,623	1,636	1,647
Buy Backs	-14.8%	3,326	3,906	4,247	4,244	4,303

Risks for MET

What is the probability of a big loss on MET?

39.6%

Probability that Metlife stock will be more than 20% underwater in next one year

19.6%

Probability that Metlife stock will be more than 30% underwater in next one year.

18.9%

Probability that Metlife stock will be more than 40% underwater in next one year.

*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does MET drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Metlife was unfortunately bought at previous high price.

Drawdowns

Returns for MET

Cumulative Returns on MET

8.5%

10-Year Cumulative Returns

9.1%

7-Year Cumulative Returns

7.7%

5-Year Cumulative Returns

26.0%

3-Year Cumulative Returns

What are the long-term rolling returns for MET?

FIve years rolling returns for Metlife.

Annualized Returns

Which funds bought or sold MET recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
2023-03-23	MetLife Investment Management, LLC	reduced	-3.22	1,647,700	12,459,000	0.10%
2023-03-23	ETF MANAGERS GROUP, LLC	added	4.27	144,602	743,602	0.04%
2023-03-17	American Portfolios Advisors	reduced	-3.31	-22,261	325,267	0.01%
2023-03-15	B. Riley Wealth Advisors, Inc.	reduced	-2.58	116,220	924,220	0.03%
2023-03-10	VICTORY CAPITAL MANAGEMENT INC	reduced	-6.57	8,485,010	83,929,000	0.09%
2023-03-10	MATHER GROUP, LLC.	reduced	-1.71	50,060	345,060	0.01%
2023-03-08	Capital Asset Advisory Services LLC	reduced	-18.16	13,413	1,179,410	0.09%
2023-03-07	Great Lakes Retirement, Inc.	new	-	6,172,190	6,172,190	1.58%
2023-03-07	Nordwand Advisors, LLC	new	-	7,708,490	7,708,490	0.96%
2023-03-06	BIRMINGHAM CAPITAL MANAGEMENT CO INC/AL	reduced	-1.08	424,706	2,810,710	1.07%

Latest Funds Activity

Are funds buying MET calls or puts?

Calls

Puts

Are funds bullish or bearish(Calls - Puts)?

Net Call Options

No. of funds that own MET

No. of Funds

Metlife News

Schedule 13G FIlings of Metlife

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 23, 2023	board of directors of metlife inc	15.9%	122,923,807	SC 13D/A
Feb 14, 2023	dodge & cox	6.8%	53,583,210	SC 13G/A
Feb 09, 2023	vanguard group inc	7.08%	55,519,588	SC 13G/A
Jan 31, 2023	blackrock inc.	7.1%	55,514,415	SC 13G/A
May 05, 2022	board of directors of metlife inc	15.6%	127,128,424	SC 13D/A
Feb 14, 2022	dodge & cox	7.0%	58,725,183	SC 13G/A
Feb 09, 2022	vanguard group inc	6.77%	56,951,725	SC 13G/A
Feb 03, 2022	blackrock inc.	8.5%	71,686,373	SC 13G/A
Nov 09, 2021	board of directors of metlife inc	15.5%	130,169,694	SC 13D/A
Aug 06, 2021	board of directors of metlife inc	15.4%	131,995,674	SC 13D/A

MET Fair Value

Metlife fair value in different scenarios

The table shows the Fair Value estimates for Metlife for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.

Fair Value	Very Pessimistic	Pessimistic	Base Case	Optimistic	Very Optimistic
Very Low Inflation	- -	6.33 -88.67%	22.20 -60.25%	60.97 9.17%	81.34 45.64%
Current Inflation	9.70 -82.63%	1.72 -96.92%	15.19 -72.80%	47.69 -14.61%	64.72 15.88%
Very High Inflation	- -	- -	6.75 -87.91%	32.20 -42.35%	45.51 -18.51%

Historical Metlife Fair Value Estimates

Very Pessimistic Case

Pessimistic Case

Fair Value

Optimistic Case

Very Optimistic Case

Closing Stock Price

Recent SEC filings of Metlife

View All Filings

Date Filed	Form Type	Document
Mar 23, 2023	13F-HR	Fund Holdings Report
Mar 23, 2023	13F-HR/A	Fund Holdings Report
Mar 23, 2023	13F-HR/A	Fund Holdings Report
Mar 23, 2023	13F-HR/A	Fund Holdings Report
Mar 23, 2023	13F-HR/A	Fund Holdings Report
Mar 23, 2023	13F-HR/A	Fund Holdings Report
Mar 23, 2023	13F-HR	Fund Holdings Report
Mar 23, 2023	13F-HR	Fund Holdings Report
Mar 23, 2023	13F-HR	Fund Holdings Report
Mar 23, 2023	13F-HR	Fund Holdings Report

Latest Insider Trading transactions for MET

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
2023-03-14	HUBBARD ROBERT GLENN	acquired	37,686	59.07	638	-
2023-03-14	Kennard William E	acquired	17,130	59.07	290	-
2023-03-14	KELLY EDWARD J III	acquired	14,413	59.07	244	-
2023-03-14	GRISE CHERYL W	acquired	36,150	59.07	612	-
2023-03-14	MCKENZIE DIANA	acquired	7,147	59.07	121	-
2023-03-14	Kinney Catherine R	acquired	17,602	59.07	298	-
2023-03-14	Herzog David L	acquired	2,835	59.07	48.00	-
2023-03-14	HASSELL GERALD L	acquired	8,447	59.07	143	-
2023-03-02	PAPPAS BILL	sold	-202,733	70.96	-2,857	evp, global tech. & ops.
2023-03-01	GAUSTER STEPHEN W	sold (taxes)	-155,084	71.27	-2,176	evp & general counsel

About Metlife

MET Income Statement

2022-12-31

Consolidated Statements of Operations - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Revenues
Premiums	$ 49,397	$ 42,009	$ 42,034
Universal life and investment-type product policy fees	5,585	5,756	5,603
Net investment income	15,916	21,395	17,117
Other revenues	2,634	2,619	1,849
Net investment gains (losses)	(1,262)	1,529	(110)
Net derivative gains (losses)	(2,372)	(2,228)	1,349
Total revenues	69,898	71,080	67,842
Expenses
Policyholder benefits and claims	50,612	43,954	41,461
Interest credited to policyholder account balances	3,692	5,538	5,214
Policyholder dividends	701	876	1,090
Other expenses	12,034	12,586	13,150
Total expenses	67,039	62,954	60,915
Income (loss) before provision for income tax	2,859	8,126	6,927
Provision for income tax expense (benefit)	301	1,551	1,509
Net income (loss)	2,558	6,575	5,418
Less: Net income (loss) attributable to noncontrolling interests	19	21	11
Net income (loss) attributable to MetLife, Inc.	2,539	6,554	5,407
Less: Preferred stock dividends	185	195	202
Preferred stock redemption premium	0	6	14
Net income (loss) available to MetLife, Inc.’s common shareholders	$ 2,354	$ 6,353	$ 5,191
Net income (loss) available to MetLife, Inc.’s common shareholders per common share:
Basic	$ 2.93	$ 7.36	$ 5.72
Diluted	$ 2.91	$ 7.31	$ 5.68

MET Balance Sheet

2022-12-31

Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Investments:
Fixed maturity securities available-for-sale, at estimated fair value (net of allowance for credit loss of $183 and $91, respectively); and amortized cost: $306,025 and $310,884, respectively	$ 276,780	$ 340,274
Equity securities, at estimated fair value	1,684	1,269
Contractholder-directed equity securities and fair value option securities, at estimated fair value	9,668	12,142
Mortgage loans (net of allowance for credit loss of $527 and $634, respectively; includes $0 and $127, respectively, under the fair value option)	83,763	79,353
Policy loans	8,874	9,111
Real estate and real estate joint ventures (includes $299 and $240, respectively, under the fair value option and $0 and $175, respectively, of real estate held-for-sale)	13,137	12,216
Other limited partnership interests	14,414	14,625
Short-term investments, principally at estimated fair value	4,935	7,176
Other invested assets (net of allowance for credit loss of $26 and $40, respectively; includes $1,926 and $1,930, respectively, of leveraged and direct financing leases; and $326 and $351, respectively, relating to variable interest entities)	20,038	18,655
Total investments	433,293	494,821
Cash and cash equivalents, principally at estimated fair value	20,195	20,047
Accrued investment income	3,446	3,185
Premiums, reinsurance and other receivables	17,461	17,149
Deferred policy acquisition costs and value of business acquired	22,983	16,061
Current income tax recoverable	42	184
Deferred income tax assets	2,830	189
Goodwill	9,297	9,535
Assets held-for-sale	0	7,238
Other assets	11,026	11,426
Separate account assets	146,038	179,873
Total assets	666,611	759,708
Liabilities
Future policy benefits	204,228	199,721
Policyholder account balances	203,082	203,473
Other policy-related balances	19,651	17,751
Policyholder dividends payable	387	478
Policyholder dividend obligation	0	1,682
Payables for collateral under securities loaned and other transactions	20,937	31,920
Short-term debt	175	341
Long-term debt	14,647	13,933
Collateral financing arrangement	716	766
Junior subordinated debt securities	3,158	3,156
Deferred income tax liability	325	9,693
Liabilities held-for-sale	0	6,634
Other liabilities	25,980	22,538
Separate account liabilities	146,038	179,873
Total liabilities	639,324	691,959
Contingencies, Commitments and Guarantees (Note 21)
MetLife, Inc.’s stockholders’ equity:
Preferred stock, par value $0.01 per share; $3,905 aggregate liquidation preference	0	0
Common stock, par value $0.01 per share; 3,000,000,000 shares authorized; 1,189,831,471 and 1,186,540,473 shares issued, respectively; 779,098,414 and 825,540,267 shares outstanding, respectively	12	12
Additional paid-in capital	33,616	33,511
Retained earnings	41,953	41,197
Treasury stock, at cost; 410,733,057 and 361,000,206 shares, respectively	(21,458)	(18,157)
Accumulated other comprehensive income (loss)	(27,083)	10,919
Total MetLife, Inc.’s stockholders’ equity	27,040	67,482
Noncontrolling interests	247	267
Total equity	27,287	67,749
Total liabilities and equity	$ 666,611	$ 759,708